What is the maximum safe dose of Coreg (carvedilol) in adults, considering formulation, patient weight, and indication (hypertension vs heart failure)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Careg (Carvedilol)

The maximum FDA-approved dose of immediate-release carvedilol is 50 mg per day (25 mg twice daily), and for the extended-release formulation (Coreg CR), the maximum is 80 mg once daily. 1

Maximum Dosing by Formulation

Immediate-Release Carvedilol

  • Total daily maximum: 50 mg (administered as 25 mg twice daily) 2, 3, 1
  • The American Heart Association and FDA drug label both confirm this ceiling dose must not be exceeded 3, 1
  • This maximum applies regardless of indication (heart failure, hypertension, or post-MI left ventricular dysfunction) 1

Extended-Release Carvedilol (Coreg CR)

  • Maximum dose: 80 mg once daily 2, 3
  • The American College of Cardiology notes this formulation provides equivalent beta-blockade to immediate-release 25 mg twice daily 2
  • For patients weighing >85 kg with heart failure, 80 mg once daily is the target dose 3

Indication-Specific Maximum Dosing

Heart Failure with Reduced Ejection Fraction (HFrEF)

  • Target dose: 25 mg twice daily (total 50 mg/day) for most patients 2, 1
  • For patients >75 kg: may use 50 mg twice daily (total 100 mg/day) 4
  • Critical caveat: The FDA label states total daily dose should not exceed 50 mg for standard dosing 1, though clinical trials in heart failure used up to 50 mg twice daily in heavier patients 4
  • Start at 3.125 mg twice daily and titrate every 2 weeks: 3.125 mg → 6.25 mg → 12.5 mg → 25 mg twice daily 1

Hypertension

  • Maximum: 50 mg per day (25 mg twice daily) 1
  • Start at 6.25 mg twice daily, increase to 12.5 mg twice daily after 7-14 days, then to 25 mg twice daily if needed 1
  • The FDA label explicitly states "total daily dose should not exceed 50 mg" for hypertension 1

Post-Myocardial Infarction with Left Ventricular Dysfunction

  • Target dose: 25 mg twice daily (total 50 mg/day) 2, 1
  • Start at 6.25 mg twice daily (or 3.125 mg twice daily if tolerability concerns), increase after 3-10 days to 12.5 mg twice daily, then to target of 25 mg twice daily 1

Weight-Based Considerations

Carvedilol dosing is NOT weight-based 3—the maximum dose remains 50 mg/day for immediate-release regardless of body weight 1. However, clinical trials in heart failure used higher doses in heavier patients:

  • Patients <75 kg: maximum 25 mg twice daily 4
  • Patients >75 kg: up to 50 mg twice daily was used in clinical trials 4

Critical Safety Warnings

Never Exceed Maximum Dose

  • The American Heart Association emphasizes that the total daily dose of immediate-release carvedilol must not exceed 50 mg, even in patients who tolerate lower doses well, because this is the FDA-approved ceiling 3
  • Exceeding this dose increases risk of severe hypotension, bradycardia, and heart failure decompensation 3

Never Stop Abruptly

  • Carvedilol should never be stopped suddenly, as abrupt cessation can trigger rebound hypertension or worsening heart failure 3
  • Taper gradually over 1-2 weeks if discontinuation is necessary 3

Titration Must Be Gradual

  • The American College of Cardiology recommends avoiding rapid uptitration; dose escalation should occur over weeks to minimize orthostatic hypotension and bradycardia 3
  • Increase dose no more frequently than every 2 weeks 2, 1

Common Pitfalls to Avoid

  • Underdosing: Many clinicians maintain patients on suboptimal doses (e.g., 12.5 mg twice daily) due to fear of side effects, missing the mortality benefit of target doses 5
  • Confusing formulations: Do not substitute immediate-release for extended-release on a 1:1 basis—they are not equivalent 6
  • Ignoring food requirement: Carvedilol must be taken with food to reduce orthostatic effects 1
  • Premature discontinuation: If side effects occur, reduce dose by 50% rather than stopping completely 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Maximum Dosage and Titration of Carvedilol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Beta Blocker Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the maximum dose of Coreg (carvedilol)?
What is the recommended dosing for Carvedilol (beta-blocker) in patients with heart failure or hypertension?
Can I increase carvedilol (Coreg) to 25 mg twice daily at a body weight of 57 kg?
What is the recommended treatment regimen for hypertension using Carvedilol (beta-blocker)?
What is the recommended dose of carvedilol (beta blocker) for patients with heart failure?
A 47-year-old asymptomatic female has a patent foramen ovale (PFO) identified on cardiac CT angiography but a negative transthoracic echocardiogram; what is the next step in management?
When should digoxin be initiated in an 87-year-old bedridden woman with left-sided heart‑failure decompensation, hypotension (systolic blood pressure <100 mm Hg), bilateral peripheral edema, and likely reduced renal function?
What is the safest and most effective first‑line antibiotic for an uncomplicated urinary tract infection in a pregnant woman?
A 20-year-old patient who has been taking metformin for three years presents with mild diarrhea; what is the most likely cause and how should it be managed?
Are proteins positively or negatively charged?
What is the cause of normochromic anemia with marked anisopoikilocytosis including acanthocytes, elliptocytes, and occasional schistocytes in an elderly woman with moderate anemia, thrombocytopenia, normal ferritin, normal serum iron, normal transferrin saturation, low total iron‑binding capacity and low unsaturated iron‑binding capacity, and normal C‑reactive protein and erythrocyte sedimentation rate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.